ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752203 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752203; 2) Community: the network communities that were significantly associated with the response to NSC 752203; 3) Molecule: the relationships between components within communities and NSC 752203; 4) MDR: the compounds that were significantly associated with the NSC 752203.

NSC Compound Enrichment Correlation
NSC 683555 Camptothecin Derivative 0.0133986477026052 -0.00049830929
NSC 693177 Ethyl 2-(5-methoxy-1-methyl-4,7-dioxoindol-3-yl)thiazole-4-carboxylate 0.0133986477026052 -0.13380378
NSC 743688 Null 0.0133986477026052 0.2571982
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0137891122538509 -0.29013504
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0137891122538509 -0.12439083
NSC 105014 Cladribine 0.013789112253851 -0.1844276
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.013789112253851 -0.1055068
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.013789112253851 0.080720235
NSC 18805 .gamma.-Thujaplicine 0.013789112253851 -0.27480738
NSC 321491 Null 0.013789112253851 0.13926127
Total:68  Current:24    [First] [Prev] [Next] [Last]